Actively Recruiting
Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2026-04-13
400
Participants Needed
1
Research Sites
170 weeks
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
F
First Affiliated Hospital of Chongqing Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a sub-study of the Preoperative Combined Iron Therapy trail in which some participants will be additionally randomized to combined iron supplementation or standarded treatment control to evaluate the impact on long-term outcomes.
CONDITIONS
Official Title
Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be at least 18 years of age.
- Scheduled for major cardiac surgery such as coronary artery bypass grafting, valve surgery, or both.
- Diagnosed with iron deficiency anemia defined by ferritin levels below 100 bcg/L or ferritin below 300 bcg/L with transferrin saturation under 25%, and hemoglobin levels between 90-130 g/L for men or 90-120 g/L for women.
- American Society of Anesthesiologists (ASA) classification Grade 1-3.
- Informed consent provided by patient or legal representative prior to participation.
You will not qualify if you...
- Contraindications to iron sucrose, ascorbic acid, or recombinant human erythropoietin.
- Fever over 37.5 C or taking non-prophylactic antibiotics.
- Body weight 50 kg or less.
- Family history of haemochromatosis or thalassaemia, transferrin saturation over 50%, or history of iron overload.
- Other blood disorders such as folic acid or vitamin B12 deficiency, haemolytic anemia, haemoglobinopathies, iron granulocytic anemia, G6PD deficiency.
- Need for emergency surgery.
- Severe liver or kidney problems (ALT or AST more than 3 times normal, creatinine more than 1.5 times normal).
- Pregnant or breastfeeding women.
- Blood transfusion, intravenous iron, or vitamin C use within 12 weeks before surgery.
- Acute blood loss or gastrointestinal bleeding before surgery.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 330100
Actively Recruiting
Research Team
Q
Qi Gao, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here